Clinical Trials Logo

Anemia clinical trials

View clinical trials related to Anemia.

Filter by:

NCT ID: NCT03263091 Terminated - Clinical trials for Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden

Start date: September 7, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether FG-4592 is safe and effective in the treatment of anemia in participants with lower risk MDS and low red blood cell transfusion burden.

NCT ID: NCT03251664 Completed - Anemia Clinical Trials

Food Groups Associated With Anaemia in Pregnant Women

Start date: October 1, 2015
Phase: N/A
Study type: Observational [Patient Registry]

This study investigates the association between locally consumed food items with anemia among pregnant women, in Addis Ababa city, Ethiopia.

NCT ID: NCT03247816 Completed - Clinical trials for Inflammatory Bowel Diseases

Feraccru® Real World Effectiveness Study in Hospital Practice ( FRESH )

FRESH
Start date: August 14, 2017
Phase:
Study type: Observational

The aim of the study is to understand the early experiences of Feraccru® in patients with inflammatory bowel disease (IBD) and iron deficiency anaemia (IDA) in the UK, including treatment effectiveness, patterns of use and tolerability.

NCT ID: NCT03246178 Enrolling by invitation - Clinical trials for Severe Aplastic Anemia

Haploidentical Transplantation in Severe Aplastic Anemia

Start date: July 10, 2017
Phase: N/A
Study type: Interventional

This is a prospective case-control study on SAA patients treated with HSCT, order to further discuss and assess the safety, feasibility and effectiveness of HFD-HSCT which performed with reduced-intensity fludarabine-based conditioning regimen.Our findings would indicate that SAA patients who lack MSD benefited most if HFD-HSCT was performed with reduced-intensity fludarabine-based conditioning regimen, and our improved outcomes with HFD-HSCT may lead to a salvaged therapy and an expanded direct role for SAA in the future.

NCT ID: NCT03242967 Withdrawn - Anemia Clinical Trials

Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)

TRILOGY
Start date: August 2017
Phase: Phase 3
Study type: Interventional

This is a Phase 3 Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects with Dialysis-Dependent Chronic Kidney Disease (DD-CKD)

NCT ID: NCT03241381 Completed - Clinical trials for Melasma, Periodontitis, Vitamin D Abnormalities, Anaemia

Prevalence of Serum-Vitamin D Abnormalities, Periodontitis and Anaemia in Patients With Melasma

Start date: October 2016
Phase: N/A
Study type: Observational

Melasma is a commonly pigmention characterized by melanotic patches on the face. literature searched revealed that periodontitis and vitamin D deficiency have occurred along with anemia. Actinic associated factors may be indirectly related to vitamin D, melasma contributes to sun exposed area of face.To correlate melasma with clinical evidence of periodontitis and vitamin D serum analysis along side hb %. Patients with facial melasma between 30-70yrs of either gender formed Group A (95). Anaemia and periodontitis were Clinically checked. Additionally serum analysis of vitamin D and hb percentage were analysed. Similar procedure was carried out on controls which had Group B (95) patients with no melasma on face. The study revealed significant correlation between melasma and periodontitis with vitamin D abnormalities (p value<.05), where as insignificant correlation between melasma and Hb%. The correlation between melasma, vitamin d changes and periodontitis may prompt the clinician to check for any such changes in any patient. Melasma in patients with periodontitis and serum vitamin D changes might be a considered as a syndrome.

NCT ID: NCT03238911 Completed - Clinical trials for Iron Deficiency Anemia

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

Start date: October 24, 2017
Phase: Phase 3
Study type: Interventional

The trial was designed to evaluate the incidence of unintended hypophosphatemia (low level of phosphate in the blood) in subjects with iron deficiency anaemia (IDA).

NCT ID: NCT03237065 Completed - Clinical trials for Iron Deficiency Anemia

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

Start date: October 30, 2017
Phase: Phase 3
Study type: Interventional

The trial was designed to evaluate the incidence of unintended hypophosphatemia (low level of phosphate in the blood) in subjects with iron deficiency anaemia (IDA).

NCT ID: NCT03236246 Completed - Clinical trials for Chronic Kidney Diseases

KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)

COMPASS
Start date: August 15, 2017
Phase: Phase 4
Study type: Interventional

The objectives of this study are to assess the long-term efficacy and safety of different dose regimens of KRX-0502 in the treatment of iron deficiency anemia (IDA) in adult subjects with non-dialysis dependent chronic kidney disease (CKD).

NCT ID: NCT03232554 Recruiting - Clinical trials for Iron-Deficiency Anemia

Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia

BXYMIDA
Start date: June 1, 2017
Phase: Phase 2
Study type: Interventional

This study evaluates Buxue Yimu Pills,Ferrous Sulfate and the addition of Buxue Yimu Pills to Ferrous Sulfate in the treatment of Iron-Deficiency Anemia in adults women. One third of participanta will receive Buxue Yimu Pills, one third of participanta will receive Buxue Yimu Pills, one third of participanta will receive Ferrous Sulfate,and the another third will receive Buxue Yimu Pills and Ferrous Sulfate in combination.